IPO Listed

Braveheart Bio IPO

US$383m raised

NASDAQ: BRVE · US$18.00 cash per share

Advisers

Braveheart Bio

Issuer

Legal adviser
Issuer
Braveheart Bio
Issuer based in
United States
Listed
6 Aug 2026
Sector
Biotech
Tags
Biotech, Cardiovascular, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.